🕵️ Adaptimmune Therapeutics PLC ($ADAPY)
SEC insider & ownership activity, last 12 months · CIK 1621227 · every row links its SEC filing
Over the last 12 months insiders sold $7.1M with no open-market buying against it. ECOR1 Capital, LLC sold $6.9M in discretionary trades (Jul). 4 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Oct 15, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 4 sellers, $7.1M (7 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| ECOR1 Capital, LLC | 0 | – | 3 | $6.9M | Jul 30, 2025 |
| Behbahani Ali | 0 | – | 2 | $229K | Aug 18, 2025 |
| William C. Bertrand Jr. | 0 | – | 1 | $2K | Aug 28, 2025 |
| Gavin Wood | 0 | – | 1 | $950 | Sep 2, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| LONG Focus Capital Master, Ltd. | 5.2% | 13G | Feb 11, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Gavin Wood | $942 | Sep 2, 2025 | filing ↗ |
| William Bertrand | $2K | Aug 28, 2025 | filing ↗ |
| New Enterprise Associates, 14 LP | $982K | Aug 15, 2025 | filing ↗ |
| New Enterprise Associates, 16 LP | $231K | Aug 15, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Delisting notice (3.01) | Oct 15, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 15, 2025 | filing ↗ |
| Delisting notice (3.01) | Sep 22, 2025 | filing ↗ |
| Delisting notice (3.01) | Sep 11, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 6, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 29, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 15, 2025 | filing ↗ |
| Delisting notice (3.01) | Aug 14, 2025 | filing ↗ |
| Earnings (2.02) | Aug 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |
| Agreement terminated (1.02) | Jul 31, 2025 | filing ↗ |
| Acquisition or disposition (2.01) | Jul 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing ↗ |